| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/01/2007 | WO2007012970A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 02/01/2007 | WO2007012944A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/01/2007 | WO2007012811A2 Prostate stem cell markers |
| 02/01/2007 | WO2007012691A1 Recombinant vectors based on the modified ankara virus (mav) as preventive and therapeutic vaccines against aids |
| 02/01/2007 | WO2007012449A1 Frizzled 9 as tumour marker |
| 02/01/2007 | WO2007012285A1 Viral infection resistent single strand deoxynucleosides |
| 02/01/2007 | WO2007012191A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | WO2006132605A3 Porcine circovirus type 2 vaccines |
| 02/01/2007 | WO2006122257A3 Nebulization of monoclonal antibodies for treating pulmonary diseases |
| 02/01/2007 | WO2006119527A8 Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use |
| 02/01/2007 | WO2006116260A3 Modulation of antibody effector function by hinge domain engineering |
| 02/01/2007 | WO2006113373A3 Novel vaccine formulations |
| 02/01/2007 | WO2006102069A3 Methods and compositions for the treatment of hypertension and gastrointestinal disorders |
| 02/01/2007 | WO2006096490A8 ANTI-MAdCAM ANTIBODY COMPOSITIONS |
| 02/01/2007 | WO2006091326A8 Anti-prl-3 antibodies and methods of use thereof |
| 02/01/2007 | WO2006091229A3 Methods of modulating intracellular degradation rates of toxins |
| 02/01/2007 | WO2006076587A3 Peptides for delivery of mucosal vaccines |
| 02/01/2007 | WO2006069262A3 Compositions of influenza viral proteins and methods of use thereof |
| 02/01/2007 | WO2006066229A3 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 02/01/2007 | WO2006042237A3 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 02/01/2007 | WO2006042177A3 Mature dendritic cell compositions and methods for culturing same |
| 02/01/2007 | WO2006033688A8 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses |
| 02/01/2007 | WO2006007398A9 Therapy of platinum-resistant cancer |
| 02/01/2007 | WO2005118622A3 Naturally processed measles virus peptides eluted from class ii hla molecules |
| 02/01/2007 | WO2005117967A3 Anti-il-9 antibody formulations and uses thereof |
| 02/01/2007 | WO2005116258A3 Influenza hemagglutinin and neuraminidase varians |
| 02/01/2007 | WO2005077082A3 INHIBITING CAV3 ISOFORMS AND THE δ25B SPLICE VARIENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| 02/01/2007 | WO2004084822A3 Methods for inducing immune tolerance |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy |
| 02/01/2007 | US20070027098 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 02/01/2007 | US20070026501 Immunogen, composition for immulogical use and process for producing antibody using the same |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026468 Tetrameric antibody complexes for blocking non-specific labeling of antigens |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026425 Hepatitis C virus Non-structural NS3/4A fusion gene |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026057 In vivo targeting of dendritic cells |
| 02/01/2007 | US20070026029 Apheresis device |
| 02/01/2007 | US20070026023 Vaccine for coccidiosis in chickens prepared from three attenuated Eimeria species composed of sporulated oocysts isolated from precocious strains: 500 oocysts of E. acervulina, 50 to 100 oocysts of E. maxima and 100 to 250 oocysts of E. tenella. |
| 02/01/2007 | US20070026022 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens |
| 02/01/2007 | US20070026021 Proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences; proteins are predicted to be useful antigens for vaccines and/or diagnostics; provides Neisserial DNA sequences which encode proteins that are antigenic or immunogenic |
| 02/01/2007 | US20070026020 Modified mycobacterium tuberculosis strains and uses thereof |
| 02/01/2007 | US20070026019 Botulinum toxin compositions |
| 02/01/2007 | US20070026018 Methods for treating, preventing and diagnosing Helicobacter infection |
| 02/01/2007 | US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 02/01/2007 | US20070026016 site-directed mutagenesis; immunogens; vaccines |
| 02/01/2007 | US20070026015 Method |
| 02/01/2007 | US20070026014 Interferon beta in severe acute respiratory syndrome (sars) |
| 02/01/2007 | US20070026013 Albumin fusion proteins |
| 02/01/2007 | US20070026012 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/01/2007 | US20070026011 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 02/01/2007 | US20070026010 Purification process for bacterial cytolysin |
| 02/01/2007 | US20070026009 Using influenza virus peptide as tool in diagnosis and treatment of viral diseases |
| 02/01/2007 | US20070026008 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070026006 Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response |
| 02/01/2007 | US20070026005 Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere |
| 02/01/2007 | US20070026003 Monoclonal antibodies; HCV enveloped subviral or purified HCV enveloped complete viral particles; hybridoma |
| 02/01/2007 | US20070026002 treatment of mammals susceptible to or diagnosed with cancer, or with relapse tumor growth or relapse cancer cell growth |
| 02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
| 02/01/2007 | US20070026000 APO-2L receptor agonist and CPT-11 synergism |
| 02/01/2007 | US20070025999 Treatment with anti-vegf antibodies |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025997 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
| 02/01/2007 | US20070025995 Taxoid derivative covalently linked to tumor-specific antibody and a method for preparing the same |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025992 Monoclonal antibody against platelet membrane glycoprotein VI |
| 02/01/2007 | US20070025991 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 02/01/2007 | US20070025990 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| 02/01/2007 | US20070025989 Administration of agents for the treatment of inflammation |
| 02/01/2007 | US20070025988 Method for Treating Lupus |
| 02/01/2007 | US20070025987 Method for Treating Vasculitis |
| 02/01/2007 | US20070025986 Modulation of HCN channels by second messengers |
| 02/01/2007 | US20070025985 Immunoglobulins devoid of light chains |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025983 Compounds capable of inhibiting HIV-1 infection |
| 02/01/2007 | US20070025982 DNA vaccines encoding antigen linked to a domain that binds CD40 |
| 02/01/2007 | US20070025981 Microorganisms for therapy |
| 02/01/2007 | US20070025980 Composition permitting muscle growth while protecting joint health |
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 02/01/2007 | US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 02/01/2007 | US20070025960 Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
| 02/01/2007 | US20070025959 Adjuvant combination formulations |
| 02/01/2007 | US20070025957 Vascular targeting of ocular neovascularization |
| 02/01/2007 | US20070025955 Tissue adhesive sealant |
| 02/01/2007 | US20070025919 Systems and methods for delivery of a therapeutic agent |
| 02/01/2007 | US20070025916 Porcine Helicobacter infection |
| 02/01/2007 | US20070025915 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | US20070025912 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 02/01/2007 | US20070025911 Breast cancer; hybridomas; cell lines; kits |
| 02/01/2007 | DE102005035568A1 Frizzled 9 als Biomarker für Substrukturen des humanen Gehirns Frizzled 9 as a biomarker for substructures of the human brain |
| 02/01/2007 | CA2657886A1 Stem cell markers |
| 02/01/2007 | CA2617353A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |